Portal hyperperfusion syndrome after prophylactic ligation of spontaneous portosystemic shunts during living donor liver transplantation: analysis of risk factors

被引：0
|
作者：
Co, J. S. [1 ]
Lin, C. C. [1 ]
Wang, C. C. [1 ]
Yong, C. C. [1 ]
Chen, C. L. [1 ]
机构：
[1] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
来源：
TRANSPLANTATION | 2019年 / 103卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-202
引用
收藏
页码：195 / 195
页数：1
相关论文
共 50 条
  • [41] Risk factors of biliary intervention by imaging after living donor liver transplantation
    Soon Kyu Lee
    Jong Young Choi
    Dong Myung Yeo
    Young Joon Lee
    Seung Kew Yoon
    Si Hyun Bae
    Jeong Won Jang
    Hee Yeon Kim
    Dong Goo Kim
    Young Kyoung You
    World Journal of Gastroenterology, 2016, 22 (07) : 2342 - 2348
  • [42] RISK FACTORS OF INTRAOPERATIVE COMPLICATIONS DURING DONOR HEPATECTOMY IN LIVING-DONOR LIVER TRANSPLANTATION
    Pirat, Arash
    Torgay, Adnan
    Balci, Sule
    Zeyneloglu, Pinar
    Karakayali, Hamdi
    Arslan, Gulnaz
    Haberal, Mehmet
    LIVER TRANSPLANTATION, 2009, 15 (07) : S90 - S90
  • [43] PORTAL VEIN OBSTRUCTION AFTER PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION
    Sakamoto, Seisuke
    Nosaka, Shunsuke
    Fukuda, Akinari
    Shigeta, Takanobu
    Kakiuchi, Toshihiko
    Miyazaki, Osamu
    Isobe, Yoshinori
    Kasahara, Mureo
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 122 - 122
  • [44] Experience of portal pressure and portal flow measurement during living donor liver transplantation
    Lin, T. L.
    TRANSPLANTATION, 2018, 102 : 233 - 233
  • [45] Risk factors for the metabolic syndrome components of hypertension, diabetes mellitus, and dyslipidemia after living donor liver transplantation
    Toshima, Takeo
    Yoshizumi, Tomoharu
    Inokuchi, Shoichi
    Kosai-Fujimoto, Yukiko
    Kurihara, Takeshi
    Yoshiya, Shohei
    Mano, Yohei
    Takeishi, Kazuki
    Itoh, Shinji
    Harada, Noboru
    Ikegami, Toru
    Soejima, Yuji
    Shimokawa, Mototsugu
    Maehara, Yoshihiko
    Mori, Masaki
    HPB, 2020, 22 (04) : 511 - 520
  • [46] Living-donor liver transplantation with renoportal anastomosis for patients with large spontaneous splenorenal shunts
    Marubashi, S
    Dono, K
    Nagano, H
    Gotoh, K
    Takahashi, H
    Hashimoto, K
    Miyamoto, A
    Takeda, Y
    Umeshita, K
    Kato, T
    Monden, M
    TRANSPLANTATION, 2005, 80 (12) : 1671 - 1675
  • [47] The Effect of Prophylactic Medication on the Incidence of Postreperfusion Syndrome in Living Donor Liver Transplantation
    Chung, Insun
    Lim, Hyun Young
    Ko, Justin S.
    Gwak, Mi Sook
    Kim, Gaab Soo
    Lee, Suk-koo
    LIVER TRANSPLANTATION, 2011, 17 (06) : S138 - S138
  • [48] Immunologic Analysis and Risk Factors for Acute Rejection in Living Donor Liver Transplantation
    Choi, H. J.
    Kim, D. G.
    Na, K. H.
    Yoo, Y. K.
    TRANSPLANTATION, 2012, 94 (10) : 408 - 408
  • [49] Management of Spontaneous Portosystemic Shunts in 231 Patients Who Underwent Living Donor Liver Transplantation: A Retrospective Study from a Single Center in Nagasaki, Japan
    Hamada, Takashi
    Hidaka, Masaaki
    Soyama, Akihiko
    Hara, Takanobu
    Imamura, Hajime
    Matsushima, Hajime
    Tanaka, Takayuki
    Adachi, Tomohiko
    Kanetaka, Kengo
    Eguchi, Susumu
    ANNALS OF TRANSPLANTATION, 2022, 27
  • [50] Left Renal Vein Ligation with Deceased Donor Orthotopic Liver Transplantation is Safe and Improves Portal Flow in Patients with Spontaneous Splenorenal Shunts: A Case Series
    Nguyen, Michelle
    Beal, Eliza
    Silski, Latifa Sage
    Alebrahim, Musab
    Black, Sylvester
    Elkhammas, Elmahdi
    Washburn, Kenneth
    El-Hinnawi, Ashraf
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 77 - 77
12345